 value MCA CA CEA discrimination metastatic breast cancer adenocarcinoma primary sites MCA CA CEA CA serum patients metastatic breast cancer patients metastatic adenocarcinoma primary sites percentile normal value distribution cut-off point positive predictive value PV+ CI MCA CI CA receiver-operating-characteristic ROC curves PV+ CA CI cut-off point exception patients MCA MCA CA patients breast cancer positive MCA CA negative CEA CA improvement PV+ CI MCA CA useful role discrimination patients metastatic breast cancer adenocarcinoma primary sites